IBBQ icon

Invesco NASDAQ Biotechnology ETF

7 hedge funds and large institutions have $63.5M invested in Invesco NASDAQ Biotechnology ETF in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
7
Holders Change
+7
Holders Change %
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$10.4M 400,000 +400,000 New
Bank of America
2
Bank of America
North Carolina
$10.4M 400,000 +400,000 New
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$10.4M 399,997 +399,997 New
CS
4
Credit Suisse
Switzerland
$10.4M 400,000 +400,000 New
Citigroup
5
Citigroup
New York
$10.4M 400,000 +400,000 New
TRCT
6
Tower Research Capital (TRC)
New York
$8.44M 325,629 +325,629 New
Mirae Asset Global Investments
7
Mirae Asset Global Investments
South Korea
$3.26M 126,000 +126,000 New
CFGS
8
Concourse Financial Group Securities
Alabama